RARE DISEASES & ORPHAN DRUGS
Product Description
Lodaat Pharma
-
Country/Region:United States
-
On CPHI since:2015
-
Certificates:4
-
Employees:100 - 249
Company types
Primary activities
Categories
Specifications
Lodaat Pharma
-
Country/Region:United States
-
On CPHI since:2015
-
Certificates:4
-
Employees:100 - 249
Company types
Primary activities
More Products from Lodaat Pharma (2)
-
Product Biosimilars, and High Value Molecules
Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules. We are looking for reputable global partners who want to expand their product line and in-license for their territory. -
Product USFDA Oral Solid Dosages
USFDA Oral Solid Dosages in major Therapeutic categories. All products are USFDA registered and available in either Zone II or Zone IV stability studies. Full dossiers available in either ECTD or CTD formats
Lodaat Pharma resources (2)
-
News Tracking Innovation with LODAAT Pharma: CPHI Frankfurt Track Interview
CPHI Frankfurt, to be held at Messe Frankfurt from October 28–30, 2025, will once again bring the pharmaceutical industry together for 3 days of collaboration and innovation. Our interview series sits down with some of our conference track sponsors and speakers to discuss key themes and trends impacting the industry.
-
Video Lodaat Introduction
This video provides an Introduction to the LODAAT team, product categories, facilities, research and innovation.